AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06467682 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: tele-exercise
Description: The 12-week tele-exercise program will be performed and supported via the USTEP digital platform, with each patient taking part in 3 training sessions per week with a 60-min duration period per training session. There will be personalized training sessions: i) warm-up and warm-down, ii) aerobic exercise, and iii) strength exercises. All tele-exercise program participants, will use wearable-based tracking to assessment the cardio-oxygenation.
Study NCT04765696 — intervention group
Intervention type: OTHER
Intervention: No intervention is administered
Description: No intervention is administered, the cohort is followed in order to evaluate the impact of housing and relocation on active ageing outcomes.
Study NCT04733404 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dragonfly Transcatheter Mitral Valve Repair System
Description: To conduct edge-to-edge repair with Dragonfly System under the guidance of transesophageal echocardiography.
Study NCT04985331 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: W-GenZD
Description: W-GenZD is a program that delivers evidence based therapy for the symptoms of mild-moderate depression and anxiety in adolescents in brief conversations with a fully automated relational agent.
Study NCT06546085 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Supervised treadmill exercise at 85% VO2max, 3x/wk for 16 weeks. Exercise duration will be adjusted based on individual VO2-heart rate (HR) relationship so that \~400 kcals will be expended during each training session.
Study NCT03717246 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Smart Latino
Description: A culturally tailored group intervention aimed at improving sleep duration and quality for Latino middle school students.
Study NCT03717246 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Basic Sleep Hygiene and Child Health
Description: A group intervention providing sleep hygiene and child health topics education to Latino middle school students.
Study NCT05801913 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-CD19-CAR CMV-specific T-lymphocytes
Description: Given IV
Study NCT05801913 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05801913 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy
Study NCT05801913 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05624593 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: P200TE
Description: The P200TE Ophthalmoscope provides widefield Scanning Laser Ophthalmoscope (SLO) fundus imaging and Optical Coherence Tomography (OCT) imaging in one device.
Study NCT05624593 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Predicate
Description: The predicate device is an optical coherence tomography system intended for in vivo imaging, axial cross-sectional, three-dimensional imaging and measurement of anterior and posterior ocular structures.
Study NCT05108480 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group
Description: This study followed the protocol designed for patients with hemophilic knee arthropathy. For its implementation, a 30-cm long15-cm diameter foam roller was used, and a ball 22 cm in length and 8 cm in diameter. The total duration of the intervention was 15 minutes, with 7 sessions per week over a period of 8 weeks. The physiotherapist who supervised the intervention followed up on all patients by telephone on a weekly basis to check for the absence of haemarthrosis during the intervention and to detect the possible need for protocol adaptations depending on the clinical situation of each patient. Each patient was individually provided with instructions as to how perform the exercises during the pretreatment evaluation, customizing the program if necessary. All patients had access to a mobile application, designed ad hoc for the research study (He-Foam®), where they could learn about the exercises through demonstration videos.
Study NCT06005298 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Screening, Brief Intervention, Referral to Treatment (SBIRT)
Description: SBIRT has been defined by SAMHSA as a comprehensive, integrated, public health approach to the delivery of early intervention for individuals with risky alcohol and drug use and the timely referral to more intensive substance abuse treatment for those who have substance abuse disorders. There is consensus that a comprehensive SBIRT model includes screening, brief intervention/brief treatment, and referral to treatment. In addition there are following characteristics:~* It is brief (e.g., typically about 5-10 minutes for brief interventions; about 5 to 12 sessions for brief treatments)~* The screening is universal.~* One or more specific behaviors related to risky alcohol and drug use are targeted.~* The services occur in a public health non-substance abuse treatment setting.~* It is comprehensive (comprised of screening, brief intervention/treatment, and referral to treatment).~* Strong research or experiential evidence supports the model's effectiveness.
Study NCT05801913 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Leukapheresis
Description: Undergo leukapheresis per SOC
Study NCT05801913 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lymphodepletion Therapy
Description: Undergo lymphodepletion chemotherapy per SOC
Study NCT05801913 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05801913 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
Description: Given IM
Study NCT05801913 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET
Study NCT05801913 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: X-Ray Imaging
Description: Undergo x-ray
Study NCT04901533 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: O-A-A
Description: patient is supine, and the therapist stands on the side to be manipulated. The cranial hand of the therapist globally grasps the patient's skull and turns the patient's neck on that same side. The caudal hand is placed on the patient's face. The technique is performed by an impulse in pure rotation on the side that the cervical region is rotated, with a helical movement.
Study NCT04901533 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cranial listening
Description: The patient is in the supine position, and the therapist sitting at the head of the patient. The therapist places his hands on the head of the patient, the thumbs touch each other, without touching the vault cranial. A perception of the cranial rhythm is carried out passively.
Study NCT03565848 — intervention group
Intervention type: PROCEDURE
Intervention: Mesenteric vascular and nerve sparing surgery in laparoscopic segmental colorectal resection
Description: Laparoscopic segmental colorectal resection performed by dissecting adherent to the intestinal wall with mesenteric vascularization and innervation entirely preserved.
Study NCT06290271 — intervention group
Intervention type: OTHER
Intervention: Intracranial artery flow pattern
Description: the cerebral blood flow patterns observed after the occluded artery has been recanalized.
Study NCT04441879 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Be a Mom Coping with Depression
Description: Be a Mom Coping with Depression is a blended cognitive-behavioral intervention for the treatment of postpartum depression. It consists of 13 weeks of face-to-face and online sessions, each session targeting a specific thematic content, and providing participants with both information and specific therapeutic strategies (with a strong focus on cognitive-behavioral techniques) to address each thematic content.
Study NCT04441879 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Be a Mom
Description: Be a Mom is an online intervention consisting of 6 modules, each one targeting a specific thematic content, and providing women with both information and specific therapeutic strategies (with a strong focus on cognitive-behavioral techniques) to address each thematic content. Women will receive biweekly phone calls from a psychologist between completion of each module to provide support.
Study NCT06490198 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OBI-833/OBI-821
Description: OBI-833 is a glycoconjugate that consists of Globo H, a unique tumor-associated carbohydrate antigen (TACA), covalently linked to cross-reacting material 197 (CRM197), an inactive and nontoxic form of diphtheria toxin (DT) acting as the carrier protein.~OBI-821 is a saponin-based adjuvant derived from the bark of the Quillaja saponaria Molina tree. It is a purified saponin adjuvant structurally similar to adjuvant QS-21. The OBI-833/OBI-821 combination represents a carbohydrate-conjugate vaccine combined with an immune adjuvant, intended to serve as an active cancer immunotherapy.
Study NCT04968340 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: conventional cs
Description: opening the lower uterine segment with introduction of the surgeon hand below the fetal head during its extraction
Study NCT04968340 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: external pop out teqnique
Description: support of lower uterine segment without introduction of the surgeon hand below the fetal head during its extraction
Study NCT04908917 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Portable Air Cleaner with a HEPA Filter
Description: A novel intervention using a portable air cleaner with HEPA filter to treat mildly high BP to potentially reduce the cardiovascular effects of PM2.5. Leave the PAC running with the HEPA filter installed on the highest setting during sleeping periods in the room in which the participant sleeps.
Study NCT04908917 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Portable Air Cleaner without a HEPA Filter
Description: Leave the PAC running without a HEPA filter installed on the highest setting during sleeping periods in the room in which the participant sleeps.
Study NCT05373121 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online Peer Support
Description: Signposting to online peer support groups and forums
Study NCT06139861 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TranS-C
Description: Transdiagnostic Sleep and Circadian Intervention (TranS-C) is an evidence based cognitive-behavioral sleep therapy.
Study NCT06139861 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation
Description: The overarching principle is to provide information about how sleep, stress, diet, health, exercise, accidents and mood are inter-related and have reciprocal effects.
Study NCT04185441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tanzânia association
Description: Tanzânia association capsule
Study NCT04185441 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omnic Ocas
Description: Tamsulosin 0,4 mg
Study NCT04185441 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Omnic Ocas placebo
Description: Tamsulosin placebo
Study NCT04185441 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tanzânia association placebo
Description: EMS association placebo
Study NCT05496894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone Hydrochloride Liposome Injection
Description: IV, once every 3 months (Q3M)
Study NCT06459622 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Serum IL_25 and eosinophils in nasal polyp tisuee
Description: Serum IL-25 and eosinophils in nasal polyps tisuer obtained and measured to identify the sensitivity of nasal polyps to corticosteroids
Study NCT06386809 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TAVNS
Description: TAVNS is a recently introduced treatment involving transcutaneous electrical stimulation of the auricular branch of the vagus nerve with VAGUSTIM device.
Study NCT06386809 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Exercise program
Description: Rocabado 6x6 exercises will be applied in our study. Rocabado exercise, which is the most commonly used exercise method in the literature, is a set of exercises for the craniocervical and craniomandibular system.
Study NCT06386809 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise program
Description: Rocabado 6x6 exercises will be applied in our study. Rocabado exercise, which is the most commonly used exercise method in the literature, is a set of exercises for the craniocervical and craniomandibular system.
Study NCT06637462 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Endoscopy
Description: Standard of care endoscopy
Study NCT05414370 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Liquid oxygen
Description: Liquid medical oxygen will be administered for 6 hours using high-flow nasal cannula delivery system with an Fi02 of 100% and flow rate of 60 litres per minute.
Study NCT05414370 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: medical air
Description: Synthetic medical air will be administered for 6 hours using high-flow nasal cannula delivery system with a flow rate of 60 litres per minute.
Study NCT05262582 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sigle port RATS
Description: The incision is performed in the 5-6th intercostal space under the breast folds without violating the mammalian tissue. This port is used for the camera and both arms simultaneously.
Study NCT05262582 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Two ports RATS
Description: The incision is performed in the 4th intercostal space along anterior axillary fossa, for the camera and left arm. The other incision is subxiphoid longitudinal incision about 4cm for the right arm.
Study NCT06390631 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure
Description: Patients with COPD were recruited to breath under the atmosphere pressure and different levels of CPAP (4, 6, 8 and 10 cm H2O).
Study NCT05271110 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Liver resection (ablation)
Description: Treatment of liver metastases from pancreatic cancer by surgery or ablation
Study NCT04831190 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Exercise Intervention
Description: The exercise program to be implemented for neuro-oncology patients will combine aerobic, resistance, balance, and flexibility exercises delivered in one-to-one setting (i.e., personal training) twice per week, for 12 weeks. Based on needs and preferences, participants will have the option to join a circuit-type group class once per week in place of one of their personal training sessions. During COVID-19, all sessions will be delivered remotely. If facilities are open and deemed safe for cancer patients, participants will have the option to attend an in-person session, integrated in the community. Whether delivered in-class or remotely, the intervention will follow exercise progression principles (i.e., frequency, intensity, time, type, overload, and progression) over the 12-weeks, with tailoring of any exercise to meet individual participant needs, with aims of promoting wellness and physical function. The exercise intervention is based on the Alberta Cancer Exercise (ACE) program.
Study NCT04134923 — intervention group
Intervention type: DRUG
Intervention: [11C] Pittsburgh Compound-B (PIB)
Description: Participants will receive a single intravenous bolus injection of 6.0 - 20.0 mCi (222-740 MBq) of the investigational radiotracer \[11C\] PIB. Participants will then undergo a \[11C\] PIB PET/CT scan conducted in the Center for Clinical Imaging Research (CCIR) facility.
Study NCT05046665 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 89Zr-Girentuximab
Description: Administration of 89Zr-girentuximab as per protocol.
Study NCT00627835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sorafenib
Description: Cohort 1 - sorafenib 200 mg PO bid concurrent with radiation
Study NCT00627835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sorafenib
Description: o Cohort 2 - sorafenib 400 mg PO bid concurrent with radiation
Study NCT00627835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sorafenib and cisplatin
Description: Cohort 3 - sorafenib 200 mg PO bid / cisplatin 75 mg/m2 weeks 1, 4 and 7
Study NCT00627835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sorafenib and cisplatin
Description: o Cohort 4 - sorafenib 400 mg PO bid/ cisplatin 75 mg/m2 weeks 1, 4 and 7
Study NCT04049500 — intervention group
Intervention type: OTHER
Intervention: Digital Diabetes Prevention Program (dDPP)
Description: dDPP tool suite to integrate with the EHR and clinical workflows
Study NCT00627835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sorafenib and cisplatin
Description: Cohort 5 - sorafenib 400 mg PO bid/ cisplatin 100 mg/m2 weeks 1, 4 and 7
Study NCT03423511 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MiStent II coronary artery stent
Description: Implantation of a coronary stent patient with stable and unstable coronary artery disease including non-ST-Elevated Myocardial Infarction
Study NCT03423511 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Xience or Promus coronary artery stents
Description: Implantation of a coronary stent patient with stable and unstable coronary artery disease including non-ST-Elevated Myocardial Infarction
Study NCT04635137 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ablation and Cementoplasty
Description: Percutaneous thermal ablation with subsequent cementoplasty in a single procedure
Study NCT04841720 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK16149
Description: HSK16149 capsules for single use: D1-D4 oral HSK16149 capsules 80 mg BID, D5 only oral HSK16149 capsules 80 mg in the morning on an empty stomach; wash-out period is about 4 days (D5-D8);
Study NCT04841720 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin Hydrochloride tablet
Description: Metformin hydrochloride tablets for single use: D9-D11 oral metformin hydrochloride tablets 500 mg BID, D12 only take 500 mg metformin hydrochloride tablets in the morning on an empty stomach; wash-out period is about 4 days (D12-D15);
Study NCT04841720 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK16149+Metformin（phase 3）
Description: Combined use of HSK16149 capsules and metformin hydrochloride tablets: D16-D19 oral metformin hydrochloride tablets 500 mg BID, D16-D19 oral HSK16149 80 mg BID; D20 oral metformin hydrochloride tablets 500 mg and HSK16149 capsules 80 mg in the morning on an empty stomach.
Study NCT05421221 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sniffin' sticks Duftquartett
Description: 4-odor training set over 12 weeks with Sniffin' sticks Duftquartett
Study NCT04870827 — intervention group
Intervention type: DRUG
Intervention: 13N Amonia
Description: Administered during PET/CT scans
Study NCT04945486 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peer-mentor intervention
Description: Peer-mentor support for up to 6 months
Study NCT05120050 — intervention group
Intervention type: DEVICE
Intervention: ASP Health instrument
Description: The instrument is an integrated device with a short processing time (measured in 2 to 3 minutes) that distributes cells from limited volume samples (measured in microliters). The process involves a novel aerosolization technique that transfers liquid sample to a glass slide via a burst of air. After the sample is deposited on the glass slide, the automated system uses an integrated heating strip to heat the specimen slide. This process is similar to using a hair dryer to dry the specimen slide in the current ROSE setting. After drying the slide, the system uses series of pumps to dispense microliters of stain reagent onto the slide to stain the cells. Currently, the system is configured to perform DiffQuik staining, which is commonly used in the ROSE process. In the future, the staining capability will be broadened to include other staining processes such as Rapid PAP, H\&E staining etc.
Study NCT05344625 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine 100 MG/ML
Description: Ketamine Assisted Psychotherapy
Study NCT05052541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THC/CBD
Description: Oral solution containing 5mg THC and 50 mg CBD per 1 ml
Study NCT05052541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THC
Description: Oral solution containing 5mg THC per 1 ml
Study NCT05052541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral solution containing no active drug
Study NCT05052541 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral solution containing no active drug
Study NCT06041646 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Sublingual film containing Igalmi
Description: Sublingual film containing 180 µg of Igalmi (dexmedetomidine)
Study NCT04828785 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MTM
Description: weekly home meal delivery; an explanation of the medical tailoring of the meals; and a 6-session telephone lifestyle intervention change program designed to complement the period of meal delivery and prepare for the period after meal delivery with behavioral and skill-building approaches to sustain the benefit of the intervention.
Study NCT04828785 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Food Subsidy
Description: $40/month food subsidy
Study NCT05516693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofacial muscle training protocol.
Description: Muscle training for orofacial motricity stimulation